Search

Dave Trong Nguyen

Supervisory Patent Examiner (ID: 2395, Phone: (571)272-0731 , Office: P/1634 )

Most Active Art Unit
1633
Art Unit(s)
1633, 1804, 1621, 1634, 1632
Total Applications
624
Issued Applications
320
Pending Applications
143
Abandoned Applications
162

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1533815 [patent_doc_number] => 06410721 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Polynucleotide decoys that inhibit MHC-II expression and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/225645 [patent_app_country] => US [patent_app_date] => 1999-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 13351 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410721.pdf [firstpage_image] =>[orig_patent_app_number] => 09225645 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/225645
Polynucleotide decoys that inhibit MHC-II expression and uses thereof Jan 4, 1999 Issued
Array ( [id] => 4320139 [patent_doc_number] => 06328957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Heat shock proteins and the treatment of tumors' [patent_app_type] => 1 [patent_app_number] => 9/225234 [patent_app_country] => US [patent_app_date] => 1999-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 5165 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/328/06328957.pdf [firstpage_image] =>[orig_patent_app_number] => 225234 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/225234
Heat shock proteins and the treatment of tumors Jan 3, 1999 Issued
Array ( [id] => 4324130 [patent_doc_number] => 06312682 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Retroviral vectors' [patent_app_type] => 1 [patent_app_number] => 9/224014 [patent_app_country] => US [patent_app_date] => 1998-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5864 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312682.pdf [firstpage_image] =>[orig_patent_app_number] => 224014 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/224014
Retroviral vectors Dec 27, 1998 Issued
Array ( [id] => 1507096 [patent_doc_number] => 06440726 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Expression vectors comprising multiple shear stress responsive elements (SSRE) and methods of use for treating disorders related to vasculogenesis and/or angiogenesis in a shear stress environment' [patent_app_type] => B1 [patent_app_number] => 09/220510 [patent_app_country] => US [patent_app_date] => 1998-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16079 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440726.pdf [firstpage_image] =>[orig_patent_app_number] => 09220510 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/220510
Expression vectors comprising multiple shear stress responsive elements (SSRE) and methods of use for treating disorders related to vasculogenesis and/or angiogenesis in a shear stress environment Dec 23, 1998 Issued
Array ( [id] => 5889071 [patent_doc_number] => 20020013283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'METHOD AND ARTICLES FOR TRANSFECTION OF GENETIC MATERIAL' [patent_app_type] => new [patent_app_number] => 09/219907 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4583 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013283.pdf [firstpage_image] =>[orig_patent_app_number] => 09219907 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/219907
Method and articles for transfection of genetic material Dec 22, 1998 Issued
Array ( [id] => 1474230 [patent_doc_number] => 06387695 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof' [patent_app_type] => B1 [patent_app_number] => 09/218590 [patent_app_country] => US [patent_app_date] => 1998-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7158 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387695.pdf [firstpage_image] =>[orig_patent_app_number] => 09218590 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/218590
DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof Dec 21, 1998 Issued
Array ( [id] => 4353702 [patent_doc_number] => 06200801 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Serpin enzyme complex receptor-mediated gene transfer' [patent_app_type] => 1 [patent_app_number] => 9/217847 [patent_app_country] => US [patent_app_date] => 1998-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 43 [patent_no_of_words] => 44205 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200801.pdf [firstpage_image] =>[orig_patent_app_number] => 217847 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/217847
Serpin enzyme complex receptor-mediated gene transfer Dec 20, 1998 Issued
Array ( [id] => 6735132 [patent_doc_number] => 20030012767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'VECTORS FOR TISSUE-SPECIFIC REPLICATION' [patent_app_type] => new [patent_app_number] => 09/210936 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12866 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20030012767.pdf [firstpage_image] =>[orig_patent_app_number] => 09210936 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/210936
Vectors for tissue-specific replication Dec 14, 1998 Issued
Array ( [id] => 4282406 [patent_doc_number] => 06267987 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake' [patent_app_type] => 1 [patent_app_number] => 9/210014 [patent_app_country] => US [patent_app_date] => 1998-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6016 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/267/06267987.pdf [firstpage_image] =>[orig_patent_app_number] => 210014 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/210014
Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake Dec 10, 1998 Issued
Array ( [id] => 1290711 [patent_doc_number] => 06630322 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Generating replicating molecules in vivo' [patent_app_type] => B1 [patent_app_number] => 09/194960 [patent_app_country] => US [patent_app_date] => 1998-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 11325 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630322.pdf [firstpage_image] =>[orig_patent_app_number] => 09194960 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/194960
Generating replicating molecules in vivo Dec 6, 1998 Issued
Array ( [id] => 1446819 [patent_doc_number] => 06369039 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'High efficiency local drug delivery' [patent_app_type] => B1 [patent_app_number] => 09/204254 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6952 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369039.pdf [firstpage_image] =>[orig_patent_app_number] => 09204254 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/204254
High efficiency local drug delivery Dec 2, 1998 Issued
Array ( [id] => 1376632 [patent_doc_number] => 06551586 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Malaria vaccine based upon the addition of a MSA1 peptide' [patent_app_type] => B1 [patent_app_number] => 09/117415 [patent_app_country] => US [patent_app_date] => 1998-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 26701 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551586.pdf [firstpage_image] =>[orig_patent_app_number] => 09117415 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/117415
Malaria vaccine based upon the addition of a MSA1 peptide Nov 26, 1998 Issued
Array ( [id] => 1139616 [patent_doc_number] => 06776986 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Inhibition of HIV-1 replication by antisense RNA expression' [patent_app_type] => B1 [patent_app_number] => 09/194300 [patent_app_country] => US [patent_app_date] => 1998-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8737 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/776/06776986.pdf [firstpage_image] =>[orig_patent_app_number] => 09194300 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/194300
Inhibition of HIV-1 replication by antisense RNA expression Nov 22, 1998 Issued
Array ( [id] => 4375727 [patent_doc_number] => 06261552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Herpes simplex virus vectors' [patent_app_type] => 1 [patent_app_number] => 9/194274 [patent_app_country] => US [patent_app_date] => 1998-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 9516 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/261/06261552.pdf [firstpage_image] =>[orig_patent_app_number] => 194274 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/194274
Herpes simplex virus vectors Nov 19, 1998 Issued
09/195367 VIRAL VECTORS WITH LATE TRANSGENE EXPRESSION Nov 17, 1998 Abandoned
Array ( [id] => 1311396 [patent_doc_number] => 06610480 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Treatment and diagnosis of cardiac hypertrophy' [patent_app_type] => B1 [patent_app_number] => 09/189618 [patent_app_country] => US [patent_app_date] => 1998-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25370 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610480.pdf [firstpage_image] =>[orig_patent_app_number] => 09189618 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/189618
Treatment and diagnosis of cardiac hypertrophy Nov 8, 1998 Issued
Array ( [id] => 6046827 [patent_doc_number] => 20020168338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS FOR NEURONAL REGENERATION AND SURVIVAL' [patent_app_type] => new [patent_app_number] => 09/178286 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34002 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168338.pdf [firstpage_image] =>[orig_patent_app_number] => 09178286 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/178286
Compositions and methods for delivery of agents for neuronal regeneration and survival Oct 22, 1998 Issued
09/176330 COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CADIOVASCULAR DISEASE Oct 21, 1998 Abandoned
Array ( [id] => 1505974 [patent_doc_number] => 06440419 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Epithelial cell targeting agent' [patent_app_type] => B1 [patent_app_number] => 09/176741 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 31066 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440419.pdf [firstpage_image] =>[orig_patent_app_number] => 09176741 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/176741
Epithelial cell targeting agent Oct 19, 1998 Issued
Array ( [id] => 4406226 [patent_doc_number] => 06271207 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Enhanced expression of transgenes' [patent_app_type] => 1 [patent_app_number] => 9/175056 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18560 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271207.pdf [firstpage_image] =>[orig_patent_app_number] => 175056 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/175056
Enhanced expression of transgenes Oct 18, 1998 Issued
Menu